Abpro Corporation (ABP )
Currency in USD Disclaimer
Subscribe Now for Delta3 AI Alerts
Don’t miss out on top stock picks and market insights. Subscribe to Delta3 AI Alerts for real-time updates and expert analysis straight to your inbox. Stay informed and maximize your investment potential.
Key Stats
Key stats represent essential financial metrics and indicators used to evaluate a company's performance and potential investment opportunities.
- Symbol ABP
- Company Abpro Corporation
- Price $2.07
- Changes Percentage 38.93
- Change 0.58
- Day Low $1.41
- Day High $3.99
- Year High $13
- Year Low $0.95
- Market Cap $106,643,502
- Price Avg 50 EMA (D) $6.55
- Price Avg 200 EMA (D) $9.96
- Exchange NASDAQ
- Volume 17,768,701
- Average Volume 298,468
- Open $1.41
- Previous Close $1.49
- EPS -0.32
- PE -6.47
- Earnings Announcement 1970-01-01 00:00:00
- Shares Outstanding $51,518,600
Company brief: ABPRO CORPORATION (ABP )
- Healthcare
- Biotechnology
- Mr. Ian Chan
- https://abpro.com
- US
- N/A
- 03-09-2022
Abpro Holdings, Inc., a biotechnology company, engages in developing antibody therapeutics for patients with immuno-oncology, ophthalmology, and autoimmunity issues. Its platform DiversImmune addresses a bottleneck in the antibody therapeutics industry. Its lead product candidates include ABP-100 for the treatment of breast, gastric, and colorectal cancers; and ABP-201 for the treatment of vascular diseases of the eye. The company has a strategic partnership with Abpro Bio Co. Ltd and NJCTTQ. The company was formerly known as Abpro Corporation and changed its name to Abpro Holdings, Inc. in November 2024. Abpro Holdings, Inc. was incorporated in 2004 and is headquartered in Woburn, Massachusetts.